查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1543978

全球移植诊断市场

Transplant Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 158 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球移植诊断市场将达到 63 亿美元

全球移植诊断市场预计 2023 年为 45 亿美元，预计到 2030 年将达到 63 亿美元，2023 年至 2030 年复合年增长率为 5.0%。分子检测技术是本报告分析的细分市场之一，预计复合年增长率为 5.7%，到分析期结束时将达到 40 亿美元。分析期间非分子检测技术领域的复合年增长率预计为4.0%。

美国市场预估12亿美元，中国预期复合年增长率8.8%

预计 2023 年美国移植诊断市场规模将达 12 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达15亿美元，2023-2030年分析期间复合年增长率为8.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 1.8% 和 5.2%。在欧洲，德国的复合年增长率预计为 2.2%。

全球移植诊断市场 - 主要趋势和驱动因素总结

什么是移植诊断以及为什么它很重要？

移植诊断是指用于评估和监测器官移植适宜性和健康状况的医学检查和程序。这些诊断包括组织配对、交叉配血和移植后监测以检测排斥或感染疾病。移植诊断透过识别合适的捐赠者、预防排斥反应和管理受者患者的健康，在确保器官移植成功方面发挥关键作用。这些诊断的准确性和可靠性对于改善移植结果和提高患者存活率至关重要。

技术创新如何影响市场？

技术创新极大地推动了移植诊断领域的发展。聚合酵素链锁反应（PCR）和次世代定序（NGS）等分子诊断技术的发展提高了组织配对和交叉配型的准确性和速度。这些技术可以更准确地识别相容的捐赠者并及早发现潜在的排斥反应。生物标记发现的进步导致了监测移植物健康和检测感染的非侵入性测试的发展。此外，人工智慧（AI）和机器学习演算法的整合增强了资料分析和预测能力，以改善移植患者的管理。这些技术进步正在扩大移植诊断的范围和有效性，并促进其在临床实践中的采用。

主要使用者是谁？

移植诊断的主要使用者包括移植中心、医院、诊断实验室和研究机构。移植中心和医院依靠这些诊断来确保器官移植的适当性和成功，并需要准确、及时的结果来指南临床决策。诊断实验室进行各种与移植相关的测试，需要高通量和可靠的诊断工具。研发机构利用移植诊断来研究移植免疫学并开发新的诊断和治疗方法，并寻求先进和创新的技术。每个使用者群体都需要提供高精度、可靠性和易用性的移植诊断，以支援器官移植中涉及的复杂且关键的过程。

移植诊断市场成长的驱动力是什么？

移植诊断市场的成长是由多种因素推动的，例如器官移植数量的增加、诊断技术的进步以及慢性病盛行率的上升。由于器官衰竭发生率的增加和移植技术的改进，对器官移植的需求不断增加，这增加了对准确可靠的移植诊断的需求。分子诊断和生物标记发现等诊断技术的进步正在提高移植诊断的准确性和速度，促进其在临床实践中的采用。糖尿病和高血压等慢性病的流行导致器官衰竭的增加，进一步推动了对移植诊断的需求。此外，政府的措施以及对移植研究和诊断工具开发的资助正在支持市场成长。

受访企业范例（11家知名企业）

  • Becton, Dickinson and Company
  • Biofortuna Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • F. Hoffmann-La Roche AG
  • GenDx
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Omixon
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP15303

Global Transplant Diagnostics Market to Reach US$6.3 Billion by 2030

The global market for Transplant Diagnostics estimated at US$4.5 Billion in the year 2023, is expected to reach US$6.3 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Molecular Assays Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Non-Molecular Assays Technology segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.8% CAGR

The Transplant Diagnostics market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Transplant Diagnostics Market - Key Trends & Drivers Summarized

What Are Transplant Diagnostics and Why Are They Critical?

Transplant diagnostics are medical tests and procedures used to evaluate and monitor the compatibility and health of organ transplants. These diagnostics include tissue typing, cross-matching, and post-transplant monitoring to detect rejection and infections. Transplant diagnostics play a crucial role in ensuring the success of organ transplants by identifying suitable donors, preventing rejection, and managing the health of transplant recipients. The accuracy and reliability of these diagnostics are essential for improving transplant outcomes and enhancing patient survival rates.

How Have Technological Innovations Impacted the Market?

Technological innovations have significantly advanced the field of transplant diagnostics. The development of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), has improved the accuracy and speed of tissue typing and cross-matching. These technologies enable more precise identification of compatible donors and early detection of potential rejection. Advances in biomarker discovery have led to the development of non-invasive tests for monitoring graft health and detecting infections. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms has enhanced data analysis and predictive capabilities, improving the management of transplant patients. These technological advancements have expanded the scope and effectiveness of transplant diagnostics, driving their adoption in clinical practice.

Who Are the Key Users and What Are Their Needs?

The key users of transplant diagnostics include transplant centers, hospitals, diagnostic laboratories, and research institutions. Transplant centers and hospitals rely on these diagnostics to ensure the compatibility and success of organ transplants, requiring accurate and timely results to guide clinical decisions. Diagnostic laboratories perform various transplant-related tests, demanding high-throughput and reliable diagnostic tools. Research institutions utilize transplant diagnostics to study transplant immunology and develop new diagnostic and therapeutic approaches, seeking advanced and innovative technologies. Each user group requires transplant diagnostics that offer high precision, reliability, and ease of use to support the complex and critical processes involved in organ transplantation.

What Is Driving Growth in the Transplant Diagnostics Market?

The growth in the transplant diagnostics market is driven by several factors, including the increasing number of organ transplants, advancements in diagnostic technologies, and the rising prevalence of chronic diseases. The growing demand for organ transplants, driven by the rising incidence of organ failure and improved transplant techniques, has increased the need for accurate and reliable transplant diagnostics. Advancements in diagnostic technologies, such as molecular diagnostics and biomarker discovery, have enhanced the precision and speed of transplant diagnostics, driving their adoption in clinical practice. The rising prevalence of chronic diseases, such as diabetes and hypertension, has led to an increase in organ failures, further fueling the demand for transplant diagnostics. Additionally, government initiatives and funding for transplant research and the development of diagnostic tools have supported market growth.

Select Competitors (Total 11 Featured) -

  • Becton, Dickinson and Company
  • Biofortuna Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • F. Hoffmann-La Roche AG
  • GenDx
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Omixon
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transplant Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Organ Failures
    • Advancements in Molecular Diagnostics
    • Growth in Personalized Medicine
    • Development of Non-Invasive Diagnostic Tools
    • Rising Adoption of Genetic Testing
    • Expansion of Organ Transplant Programs
    • Innovations in Biomarker Discovery
    • Increasing Funding for Transplant Research
    • Growth in Point-of-Care Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Molecular Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Non-Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Non-Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Non-Molecular Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Reagent & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Reagent & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Reagent & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Transplant Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • JAPAN
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • CHINA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • EUROPE
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • FRANCE
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • GERMANY
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • INDIA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • AFRICA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION